Journal for ImmunoTherapy of Cancer (Aug 2021)
Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
Abstract
No abstracts available.
